This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
G-quadruplexes: a promising target for cancer therapy
Molecular Cancer Open Access 25 February 2021
-
Structural insight for the recognition of G-quadruplex structure at human c-myc promoter sequence by flavonoid Quercetin
Scientific Reports Open Access 15 June 2017
-
Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: Hirsutanol A inhibits tumor growth through ROS production
Journal of Translational Medicine Open Access 08 February 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hurley LH, Wheelhouse RT, Sun D, Kerwin SM, Salazar M, Fedoroff OY et al. G-quadruplexes as targets for drug design. Pharmacol Ther 2000; 85: 141–158.
Lemarteleur T, Gomez D, Paterski R, Mandine E, Mailliet P, Riou JF . Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase. Biochem Biophys Res Commun 2004; 323: 802–808.
Hurley LH . DNA and its associated processes as targets for cancer therapy. Nat Rev Cancer 2002; 2: 188–200.
Halder K, Chowdhury S . Kinetic resolution of bimolecular hybridization versus intramolecular folding in nucleic acids by surface plasmon resonance: application to G-quadruplex/duplex competition in human c-myc promoter. Nucleic Acids Res 2005; 33: 4466–4474.
Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH . Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci USA 2002; 99: 11593–11598.
Grand CL, Han H, Munoz RM, Weitman S, Von Hoff DD, Hurley LH et al. The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo. Mol Cancer Ther 2002; 1: 565–573.
Zhou JM, Zhu XF, Lu YJ, Deng R, Huang ZS, Mei YP et al. Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines. Oncogene 2006; 25: 503–511.
Tahara H, Shin-Ya K, Seimiya H, Yamada H, Tsuruo T, Ide T . G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3′ telomeric overhang in cancer cells. Oncogene 2006; 25: 1955–1966.
Acknowledgements
This work was supported by grants from the National Nature Science Foundation of China (30400556, 20472117) and the Fund of Southern China National Research Center for Integrated Biosciences and the specialized Research Fund for the Doctoral program of Higher Education (20060558038).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, JN., Deng, R., Guo, JF. et al. Inhibition of myc promoter and telomerase activity and induction of delayed apoptosis by SYUIQ-5, a novel G-quadruplex interactive agent in leukemia cells. Leukemia 21, 1300–1302 (2007). https://doi.org/10.1038/sj.leu.2404652
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404652
This article is cited by
-
Bioactive nutraceuticals as G4 stabilizers: potential cancer prevention and therapy—a critical review
Naunyn-Schmiedeberg's Archives of Pharmacology (2023)
-
G-quadruplexes: a promising target for cancer therapy
Molecular Cancer (2021)
-
Modern methods for the synthesis of δ-carbolines
Russian Chemical Bulletin (2019)
-
Structural insight for the recognition of G-quadruplex structure at human c-myc promoter sequence by flavonoid Quercetin
Scientific Reports (2017)
-
Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: Hirsutanol A inhibits tumor growth through ROS production
Journal of Translational Medicine (2013)